Search

Displaying results 1371 - 1380 of 10000 in total
  1. Drug

    D-Glutamine

    go.drugbank.com/drugs/DB02174
    Experimental

    A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia.

    Synonyms: D-2-Aminoglutaramic acid, D-Glutaminsäure-5-amid
  2. Drug

    B-2-Octylglucoside

    go.drugbank.com/drugs/DB03152
    Experimental

    Synonyms: B-2-Octylglucoside
  3. Drug

    N~2~-Succinylornithine

    go.drugbank.com/drugs/DB03582
    Experimental

    Synonyms: N~2~-Succinylornithine
  4. Drug

    2'-cytidylic acid

    go.drugbank.com/drugs/DB03765
    Experimental

    Categories: Heterocyclic Compounds, 1-RingSynonyms: 2'-CMP, 2'-cytidylic acid
  5. Drug

    2-Phosphoglycolic Acid

    go.drugbank.com/drugs/DB02726
    Experimental

    Synonyms: 2-Phosphoglycolic Acid
  6. Drug

    2-oxopropyl-CoM

    go.drugbank.com/drugs/DB03163
    Experimental

    Synonyms: 2-(2-Oxopropylthio)ethanesulfonate, 2-[(2-Oxopropyl)sulfanyl]ethanesulfonic acid
  7. Drug

    Rezafungin

    go.drugbank.com/drugs/DB16310
    ApprovedInvestigational

    Rezafungin has a half-life higher than 130 hours and can be administered once a week instead of daily. … [L45633,L45658] It was subsequently approved in the EU in November of the same year. [L52745]

    Categories: Heterocyclic Compounds, 1-RingSynonyms: Echinocandin B, 1-((4R,5R)-4-hydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-5-(2-(trimethylammonio)ethoxy)-l-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxyphenyl)-l-allothreonine)-
  8. Drug

    CP-778875

    go.drugbank.com/drugs/DB19211
    Investigational

    CP-778875 is under investigation in clinical trial NCT00326326 (Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.).

    Synonyms: 5-(((4-((4-ETHYLBENZYL)THIO)PHENYL)AMINO)SULFONYL)-2-METHYLBENZOIC ACID, Benzoic acid, 5-(((4-(((4-ethylphenyl)methyl)thio)phenyl)amino)sulfonyl)-2-methyl-
  9. Drug

    5-Methoxy-N,N-diisopropyltryptamine

    go.drugbank.com/drugs/DB01441
    ExperimentalIllicit

    5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, … Since 1999, there has been a growing popularity of 5-MeO-DIPT among drug abusers. This substance is abused for its hallucinogenic effects.

    Synonyms: N-(1-methylethyl)-N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}propan-2-amine, 5-MeO-DIPTCategories: Heterocyclic Compounds, 2-Ring, Cytochrome P-450 Substrates
  10. Drug

    Ibrexafungerp

    go.drugbank.com/drugs/DB12471
    Approved

    Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as a vaginal yeast … [A235414,L34349] Ibrexafungerp was granted FDA approval on 1 June 2021.[L34349]

    Synonyms: (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)- 2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8- ((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4- TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B, enfumafungin derivative B-(1,3)-D-glucan synthestis inhibitorCategories: P-glycoprotein substrates, Cytochrome P-450 Substrates